Jake Weber is the Co-Editor and Senior Investment Specialist of Biotech Millionaire, a premium trading service published by Mauldin Economics that focuses on small-cap, pre-revenue companies with promising pipeline candidates in critical trials. With over 12 years of professional investment experience, Jake’s expertise spans in a wide range of asset classes, including precious metals, commodities, currency and equity options, fixed income, and the healthcare and biotech sectors. Prior to joining Mauldin in 2017, he was a fixed-income trader at a proprietary trading firm in Chicago, and a Senior Editor and Investment Strategist at Casey Research for over 3 years.